Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.

From: TSS ()
Subject: Disease Emergence and Resurgence: The Wildlife-Human Connect AND WEAPONS OF MASS DESTRUCTION
Date: March 30, 2006 at 2:24 pm PST

Disease Emergence and Resurgence: The Wildlife-Human Connect
Thu Mar 30, 2006 16:45

Disease Emergence and Resurgence: The Wildlife-Human Connection

The USGS National Wildlife Health Center is pleased to announce the publication of Circular 1285 -- Disease Emergence and Resurgence: The Wildlife-Human Connection. This book was prepared in cooperation with the U.S. Fish and Wildlife Service. Major funding support was provided by the U.S. Fish and Wildlife Service, Division of Federal Assistance, Administrative Grant No. AP95-017.

The book is available for download in Adobe pdf format. By downloading and printing each of these files, you can reproduce the entire Circular 1285. You will need to have Adobe Acrobat Reader installed on your system to read pdf files. (Adobe Acrobat Reader download site)

The complete book as a single zipped PDF is available here. The individual sections of the book are available below.


Chapter 5

Is This Safe to Eat?

"A crust eaten in peace is better than a banquet attended by anxiety." (Aesop, 6th century B.C.)

"There is no love sincerer than the love of food." (George Bernard Shaw)


Brain abscesses are occasionally found by deer hunters, but these lesions do not pose a health threat for humans and should not result in disposal of the carcass. These abscesses are thought to result from invasion by skin-inhabiting bacteria. They are much more prevalent in males than females, often are associated with the antler pedicel, and generally occur following velvet shedding to shortly after the antlers are shed.20 Brain tissue from infected animals should be discarded. Even if not infected, brain should no longer be utilized in any foods because of the emergence of chronic wasting disease (see Prions, this chapter).


Prion diseases continue to be a relatively little understood yet heavily studied group of emerging infectious diseases. They include scrapie, a long existing sheep disease; bovine spongiform encephalopathy (BSE) of cattle; Creutzfeld-Jacob disease (CJD) and kuru of humans; a variant CJD (vCJD) associated with BSE that causes disease in humans; mink spongiform encephalopathy; and most recently chronic wasting disease (CWD) of deer and elk.30,31CWD is of great concern to hunters and game ranchers as it is ultimately fatal and affects several deer species (Fig. 5.28). Unlike the vCJD associated with BSE, no link has been found between CWD and disease in humans. However, because there are many unanswered questions about CWD, health officials advise against consuming meat from animals known to be infected with CWD. In addition, hunters should wear disposable gloves when field dressing deer or elk taken in areas where this disease is found and when deboning meat. The purpose for deboning is to remove associated neural tissue, the consumption of which is considered to be the primary pathway for exposure to prions. A separate knife, not the one used to butcher the deer, should be used to sever the spinal cord when the head is removed. This precaution avoids contamination of the primary butcher knife by nerve tissue that may contain the disease agent if the animal was infected. Also, avoid handling and consuming brain, spinal cord, lymph nodes, eyes, tonsils, and spleen when processing deer and elk from areas where CWD is known to be present.30–32 Complete instructions on handling, testing, and disposing of deer and elk carcasses can be obtained from the Department of Natural Resources in the state where the deer or elk are to be harvested. Observations of deer or elk with the appearance of CWD should be reported to that agency.

Figure 5.28 Clinical signs and the unthrifty appearance of animals, rather than internal pathology, are indications of the potential that a deer or other cervid is infected with chronic wasting disease. Testing of appropriate tissue is required for a diagnosis.

Appendix C. Agents that require specific government approval for scientific investigations within the USA.a

Select agents, U.S. Department of Health and Human Services onlyb
High consequence pathogens and agents, U.S. Department of Agriculture onlyc
HIgh consequence livestock pathogens and toxins, overlap agents and toxinsd

(NO HUMAN TSE LISTED ???...tss) BSE agent


7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73

Greetings list members,

confusious asks;

WHY is it that BSE is listed as ;

Appendix C. Agents that require specific government approval for scientific investigations within the USA.a. ...


COULD you not do the same with a human TSE or other animal TSE ???

THE way the human tissue donor organ situation and the black market of that is set up, would not be too hard. ...

PRODUCTa) Product is 1.0 cc Regenaform® RT. SINGLE PATIENTUSE ONLY. Recall #
Z-0481-06;b) OPTEFORM Allografts of varying sizes. SINGLE PATIENTUSE ONLY.
Recall # Z-0482-06;c) Product is OPTEFORM Allograft Paste of varying
sizes.SINGLE PATIENT USE ONLY. Recall # Z-0483-06;d) OPTEFORM® RT Moldable
Allograft of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0484-06;e)
Osteofil + RT Allograft Paste in varying sizes.SINGLE PATIENT USE ONLY.
Recall # Z-0485-06;f) Osteofil Allograft Paste (Bio) of varying sizes.SINGLE
PATIENT USE ONLY. Recall # Z-0486-06;g) Osteofil IC Syringeable of varying
sizes. SINGLEPATIENT USE ONLY. Recall # 0487-06;h) Osteofil ICM Moldable
Strip of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0488-06;i)
Osteofil RT, ICM Allograft Paste of varying sizes.SINGLE PATIENT USE ONLY.
Recall # Z-0489-06;j) OSTEOFIL® DBM Paste of varying sizes. SINGLEPATIENT
USE ONLY. Recall # Z-0490-06;k) OsteoPack 3 FZ 22cc. SINGLE PATIENT USE
ONLY.Recall # Z-0491-06;l) Regenafil IC. SINGLE PATIENT USE ONLY.Recall #
Z-0492-06;m) REGENAFORM RT Allograft Paste, 1cc. SINGLEPATIENT USE ONLY.
Recall # Z-0493-06;n) Product is REGENAFORM® Allograft Moldable Blocks,of
varying sizes. SINGLE PATIENT USE ONLY.Recall # Z-0494-06;o) Product is RTI
Allograft Paste of varying sizes.SINGLE PATIENT USE ONLY. Recall #
Z-0495-06;p) Product is REGENAFIL® Allograft Paste, Syringe,0.5cc. SINGLE
PATIENT USE ONLY. Recall # 0496-06;q) Product is 1.0cc flowable paste from
donorapproved for distribution in Italy. SINGLEPATIENT USE ONLY. Recall #
Z-0497-06;r) Product is OPTEFIL Allograft Paste of varyingsizes. SINGLE
PATIENT USE ONLY. Recall# Z-0498-06;s) Product is OPTEFIL Allograft Paste,
Syringeof varying sizes. SINGLE PATIENT USE ONLY.Recall # Z-0499-06;t)
Product is OPTEFORM® Allograft Full Disc,5 x 90mm, 32cc, Frozen. SINGLE
PATIENT USEONLY, Recall # Z-0500-06;u) Product is 2.0 cc Opteform® RT.
SINGLEPATIENT USE ONLY. Recall # Z-0501-06CODE2879130 2879131 2879132
2879133 2879134 2879135 2879136 2879137 28791382879139 2879350 2879351
2879352 2879353 2879354 2879355 2879440 28794412879442 2879443 2879444
2879445 2879446 2879447 2879448 2879449 28794502879451 2879452 2879453
2879454 2879455 2879456 2879457 2879458

snip...literally 100s and 100s and 100s, much to many recalls to post here,
first few and last few lines posted here... TSS

2667981 2667983 2667984 2667985 26679872667988 2667989 2669552 2669553
2669554 2669556 2669559 2669633 26696362669639 2669640 2669965 2669967
2669968 2669969 2669981 2669983 2669985

RECALLING FIRM/MANUFACTURERRegeneration Technologies, Inc., Alachua, FL, by
letter on October 14, 2005.Firm initiated recall is ongoing.

REASON The tissue was collected from donors for whom there is

___no verifiableidentity or consent___.

The medical records and social histories of the donorscannot be ascertained.
The devices which incorporate these donor bonetissues undergo processing,
including sterilization, which has beenvalidated to inactivate and/or remove
all viral diseases for which humantissue donors are tested.


Nationwide and Internationally END OF ENFORCEMENT REPORT FOR FEBRUARY 15,


FDA Public Health Notification: Update of Information about BioMedical Tissue Services
Posted: 3/2/2006

FDA Public Health Notification*:
Update of Information about BioMedical Tissue Services

March 2, 2006

FDA is issuing an update to its October 26, 2005, information paper on BioMedical Tissue Services (BTS) ( to strongly recommend that health care providers inform their patients who received tissue implants prepared from BTS donors that they may be at increased risk of communicable disease transmission and to offer them testing. As part of its ongoing investigation, FDA has become aware of additional information regarding the reliability of donor blood samples that is important for health care providers to consider.


On October 26, 2005, FDA issued an information paper regarding its investigation of BTS ( FDA expressed concern that BTS had supplied tissue from donors that had not been subject to an adequate donor eligibility determination. FDA and CDC recommended that health care providers inform their patients of this potential risk and offer to provide access to appropriate infectious disease testing.


full text ;

confusious is confused again in sunny Bacliff, Texas


Follow Ups:

Post a Followup

E-mail: (optional)


Optional Link URL:
Link Title:
Optional Image URL: